Benign diagnosis by image-guided core-needle breast biopsy

Duncan, J. L., Cederbom, G. J., Champaign, J. L., Smetherman, D. H., King, T. A., Farr, G. H., Waring, A. N., Bolton, J. S. and Fuhrman, G. M. (2000). Benign diagnosis by image-guided core-needle breast biopsy. In: 67th Annual Meeting of the Southeastern Surgical Congress, Tampa, FL, United States, (5-9). 13-17 February 1999.

Author Duncan, J. L.
Cederbom, G. J.
Champaign, J. L.
Smetherman, D. H.
King, T. A.
Farr, G. H.
Waring, A. N.
Bolton, J. S.
Fuhrman, G. M.
Title of paper Benign diagnosis by image-guided core-needle breast biopsy
Conference name 67th Annual Meeting of the Southeastern Surgical Congress
Conference location Tampa, FL, United States
Conference dates 13-17 February 1999
Journal name American Surgeon   Check publisher's open access policy
Publisher Southeastern Surgical Congress
Publication Year 2000
Sub-type Fully published paper
ISSN 0003-1348
1555-9823
Volume 66
Issue 1
Start page 5
End page 9
Total pages 4
Language eng
Abstract/Summary Image-guided core-needle breast biopsy (IGCNBB) is widely used to evaluate patients with abnormal mammograms; however, information is limited regarding the reliability of a benign diagnosis. The goal of this study was to demonstrate that a benign diagnosis obtained by IGCNBB is accurate and amenable to mammographic surveillance. Records of all patients evaluated by IGCNBB from July 1993 through July 1996 were reviewed. Biopsies were classified as malignant, atypical, or benign. All benign cases were followed by surveillance mammography beginning 6 months after IGCNBB. Of the 1110 patients evaluated by IGCNBB during the study period, 855 revealed benign pathology. A total of 728 of the 855 patients (85%) complied with the recommendation for surveillance mammography. A total of 196 IGCNBBs were classified as malignant; 59 cases were classified as atypical. The atypical cases were excluded from the statistical analysis. Only two patients have demonstrated carcinoma after a benign IGCNBB during the 2-year minimum follow-up period. The sensitivity and specificity of a benign result were 100.0 and 98.9 per cent, respectively. A benign diagnosis obtained by IGCNBB is accurate and therefore amenable to mammographic surveillance. The results of this study support IGCNBB as the preferred method of evaluating women with abnormal mammograms.
Keyword LOCALIZATION BIOPSY
WIRE LOCALIZATION
STEREOTAXIC CORE
FOLLOW-UP
LESIONS
Q-Index Code E1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Conference Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 12 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 14 Mar 2011, 20:49:52 EST